April 24, 2017 by Chain Drug Review
Alden Global Capital, Fred's, Fred's board of directors, Fred's Pharmacy, Heath Freeman, Michael Bloom, Steven Rossi, Thomas Tashjian, Timothy Barton, Walgreens-Rite Aid merger
Business, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Inc. has appointed two new board members as part of an agreement with hedge fund Alden Global Capital LLC, the discount and pharmacy chain’s largest shareholder. Fred’s said Monday that Steven Rossi, chief executive officer of Digital First Media, and Timothy Barton, founder and former CEO of Freightquote.com, have been named
April 24, 2017 by Chain Drug Review
Adam Fein, Affordable Care Act, American Health Care Act, Bob Kirby, CFRA, chain drug industry, chain drug stores, David Silverman, Drug Channels Institute, Fitch Ratings, Fred's, health insurance coverage, Joseph Agnese, Pembroke Consulting, Walgreens-Rite Aid merger
2017, Business, Featured Articles, Issue 04-24-2017, Issues, Leading Headlines, News, Retail News
NEW YORK — Entering the second quarter of 2017, the chain drug industry was awaiting answers to a couple of big, lingering questions. First, what will the chain drug landscape look like? A significant change in the field of players is likely in store pending antitrust clearance of Walgreens Boots Alliance Inc.’s (WBA’s) deal to
April 19, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
CDR Blog
Rite Aid saw its stock price sink to a 52-week low on Wednesday after a report that the Federal Trade Commission may challenge the drug chain’s acquisition by larger rival Walgreens Boots Alliance. Citing trade publication The Capital Forum, Bloomberg reported that the FTC was mulling a lawsuit to block the deal. Rite Aid’s share
April 6, 2017 by Chain Drug Review
Fred's, Fred's Pharmacy, Linda Longo-Kazanova, Michael Bloom, Steven Fitzpatrick, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
Business, Featured Articles, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Inc. reported declined sales and net losses for its 2016 fourth quarter and fiscal year as it awaits regulatory approval to buy up to 1,200 drug stores in connection with the Walgreens-Rite Aid merger. Fred’s said Thursday that sales for the fourth quarter ended Jan. 28, 2017, fell 4.5% to $529.7
April 5, 2017 by Chain Drug Review
Duane Reade, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Despite an uptick in its Retail Pharmacy USA division, Walgreens Boots Alliance (WBA) reported declined sales for its fiscal 2017 second quarter, with adjusted earnings per share in line with Wall Street’s consensus estimate. Also on Wednesday, WBA had no further news to report on the status of the antitrust review of
April 4, 2017 by Chain Drug Review
Fred's, Jim Cramer, Scott Mushkin, video, Walgreens Boots Alliance, Walgreens-Rite Aid, Walgreens-Rite Aid merger, Wolfe Research
Videos
Like everyone else waiting for the wrap-up of the Walgreens-Rite Aid merger, investment pundit Jim Cramer of TheStreet.com and CNBC’s “Mad Money” is getting impatient over the plodding antitrust review negotiations. Now approaching its 18th month, Walgreens Boots Alliance’s planned acquisition of Rite Aid has a deal end date of July 31, as per an
March 31, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Maureen Ohlhausen, Rite Aid, Sean Reyes, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Walgreens Boots Alliance has gone ahead and set a deadline for the Federal Trade Commission to approve its deal to acquire Rite Aid Corp. According to the New York Post, WBA has “certified compliance” in its application, meaning that it has provided the FTC with the information needed to determine if the Walgreens-Rite Aid merger
March 15, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
CDR Blog, Leading Headlines
The latest scuttlebutt on the Walgreens-Rite Aid merger: Walgreens Boots Alliance looks to be divesting even more stores and other assets to Fred’s. Citing anonymous sources, Bloomberg reported Tuesday that WBA is “nearing an agreement” to raise the number of stores to sell to Fred’s as well as include distribution centers, software and staff. No
March 8, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
It has been over 14 months and two deal date extensions since the announcement of Walgreens Boots Alliance’s agreement to acquire Rite Aid Corp. Now WBA may act to push the Federal Trade Commission to come to a decision. The New York Post reported that WBA may claim that it has “certified compliance” in its
February 27, 2017 by Scot Meyer and Chain Drug Review
Federal Trade Commission, Fred’s Inc., Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
2017, Issue 02-27-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. have extended the end date for their merger by six months, and have indicated a willingness to sell up to 1,200 Rite Aid stores to win Federal Trade Commission approval for the deal. Originally WBA said it was willing to divest up to
February 27, 2017 by David Pinto and Chain Drug Review
chain drug industry, David Pinto, Rite Aid, Rite Aid acquisition, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
2017, Issue 02-27-2017, Issues, Opinion
The major question in mass retailing this year, as the industry concludes the second month of 2017, is when — and indeed whether — Walgreens Boots Alliance’s acquisition of Rite Aid will be fruitfully concluded. As anyone who really cares knows by now the deadline for finalizing the Walgreens-Rite Aid merger has been extended to
February 16, 2017 by CDR Blog and Chain Drug Review
Abbott "Tad" Lipsky, Federal Trade Commission, Fred's, FTC Bureau of Competition, Maureen Ohlhausen, New York Post, Walgreens-Rite Aid deal, Walgreens-Rite Aid merger
CDR Blog
After being announced well over a year ago and endless speculation, it looks like the Federal Trade Commission is set to sign off on Walgreens Boots Alliance’s planned acquisition of Rite Aid Corp. The New York Post reported late Wednesday evening that WBA is bullish that it’s latest store divestiture proposal will sway the FTC
February 6, 2017 by Chain Drug Review
drug store marketplace, Federal Trade Commission, Fred's, Rite Aid, Rite Aid stores, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Inc. has amended a revolving credit facility in the event that it must acquire additional Rite Aid stores in connection with the pending Walgreens-Rite Aid merger. According to a filing with the Securities and Exchange Commission, Fred’s is increasing its revolving loan commitment to $225 million from $150 million. Among other
February 6, 2017 by Geoff Walden and Chain Drug Review
CVS Health, David Denton, Edith Ramirez, Federal Trade Commission, Fred's, Maureen Ohlhausen, Rite Aid, Stefano Pessina, Terrell McSweeny, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 02-06-2017, Issues, News
WASHINGTON — The acquisition of Rite Aid Corp. by Walgreens Boots Alliance (WBA) Inc. remained unconsummated after WBA’s plan to divest 865 stores failed to erase antitrust regulators’ competitive concerns. When the Friday, January 27, deadline for completing the Walgreens-Rite Aid merger deal arrived, the Federal Trade Commission still hadn’t cleared the transaction, despite the